A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, according to a preclinical study by Weill Cornell Medicine investigators.
Many individuals seeking asylum in the United States show increased stress and pain symptoms that are associated with indications of cardiovascular disease, according to Weill Cornell Medicine researchers.
A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease.
Two friends who bonded over shared concerns over their bone health have formulated a bioavailable calcium chew using milk protein from Finger Lakes dairy farms.
Weill Cornell Medicine researchers found that the possibility of parental disclosure through online patient portals led older adolescents to hesitate in sharing complete health information with doctors.
People with diabetes who were taking GLP-1 receptor agonist drugs had significantly lower rates of hospital readmission, wound reopening and hematoma after surgery, according to new study.
The newest episode of the Startup Cornell podcast features Jamey Edwards '96 MBA '03, president & chief strategy officer at Koko Home, a company providing radar driven, AI-enabled solutions for healthcare and an Entrepreneur in Residence of StartUp Health, which was founded in 2011 to invest in global health entrepreneurs.
Weill Cornell Medicine has received a four-year, $1.4 million grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.